Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Is Maharashtra having a Medical Meltdown? 500+ Appointments cancelled as Specialists Opt Out

Farhat Nasim26 Feb 2025 3:43 PM IST

Mumbai: Maharashtra's public healthcare system is likely to reel under a worsening staffing crisis, as more than 500 specialist doctors have refused...

Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA

Farhat Nasim24 Feb 2025 5:12 PM IST

Vonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.

Bariatric Surgery Claim Rejection Overturned! Court Orders Rs 3.4 Lakh Payout

Farhat Nasim23 Feb 2025 11:00 AM IST

Surat: Signifying that an insurer cannot deny mediclaims without concrete evidence of pre-existing treatment, the Surat Consumer Disputes Redressal...

Non-Compliance! CAT attaches GMC Principal's Salary

Farhat Nasim23 Feb 2025 9:30 AM IST

Jammu: The Central Administrative Tribunal (CAT), Jammu Bench, has ordered the attachment of the salary of the Principal, Government Medical...

Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity

Lupin Gets Rs 18 Crore Relief as HC Bars Arbitrary Tax Reassessment

Farhat Nasim22 Feb 2025 4:28 PM IST

Mumbai: In a major relief to pharma giant Lupin Limited, the Bombay High Court has quashed a reassessment notice issued under Section 148 of the...

AP HC Suggests Petitioners to Move to the Supreme Court Regarding Domicile Issue in Medical Admissions

University slapped Rs 7 lakh compensation over improper MBBS seat allotment

Farhat Nasim22 Feb 2025 2:53 PM IST

Amaravati: The Andhra Pradesh High Court has directed Dr NTR University of Health Sciences to pay Rs 7 lakh in compensation to a medical aspirant who...

Action taken against 694 manufacturing units since 2022: Minister

Folic Acid Dosage Mislabeling: CDSCO Panel Proposes Urgent Correction in Drug Rules

Farhat Nasim21 Feb 2025 5:09 PM IST

New Delhi: The Drugs Consultative Committee (DCC) has moved to enhance accuracy in drug labeling by recommending a correction in the unit of...

CDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality Checks

Farhat Nasim19 Feb 2025 6:13 PM IST

New Delhi: The growing threat of spurious drugs in India has prompted drug regulators to take a more aggressive stance. The Drugs Consultative...

Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, Marketers

Farhat Nasim18 Feb 2025 7:54 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has directed all drug manufacturers and marketers to reduce the Maximum Retail...

USFDA issues EIR for Cohance Lifesciences Telangana facility

CDSCO, Drug Officials Intensify Inspections in TN Over Alleged Rabbit Blood Hair Oil Sales

Farhat Nasim18 Feb 2025 7:53 PM IST

Combaitore: The Central Drugs Standard Control Organization (CDSCO) and Tamil Nadu Drugs Control Department have intensified inspections at hair oil...

Granules recalls over 33000 bottles BP medication in US

Glenmark, FDC Recall Hypertension, Glaucoma Drugs in US

Farhat Nasim17 Feb 2025 8:17 PM IST

New Delhi: Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, according to the US...

USFDA to appoint George Tidmarsh as top drug regulator: Report

Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management

Farhat Nasim17 Feb 2025 7:56 PM IST

New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok